Global Albumin & Creatinine Tests Market By Product (Dipsticks & Kits, Analyzers, Cartridges), By Test (Urine Tests, Blood & Serum Creatinine Tests), By End-User (Hospitals & Clinics, Diagnostic Laboratories, Research Laboratories & Institutes), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2031

Albumin and Creatinine Tests Market Introduction:

Albumin and Creatinine Tests Market: Albumin & creatinine tests are done to check for the early detection of kidney diseases. A major protein present in the blood is albumin, and virtually no urine is present if the kidneys are not functioning properly. A microalbumin test detects the amount of albumin present in the urine for diagnosis of kidney diseases. Tests for creatinine and albumin are done on a urine sample collected randomly and Albumin-To-Creatinine (ACR) ratio is calculated. This test is done to provide a more accurate diagnosis of how much albumin is being released through the urine.

The liquid portion of blood is known as plasma and contains different proteins including albumin. One of the key functions of kidneys is to stop plasma proteins from being released along with the urine. The byproduct of muscle metabolism, creatinine is normally released at a constant rate through the urine. This test result provides data on how well kidneys are functioning in filtering waste from the blood. Creatinine is leftover from muscles after the energy-producing process and is then flushed out by kidneys.

The global albumin & creatinine tests market is segmented on the basis of –  product type, test type, end-user, and region. Detailed segmentation is below:

By Product Type

• Dipsticks & Kits
• Analyzers
• Cartridges
  • Cartridges for POC Analyzers
  • Cartridges for Table-Top Analyzers

By Test Type

• Urine Tests
  • Urine Albumin Tests
  • Urine Creatinine Tests
  • Glycated Albumin
• Blood & Serum Creatinine Tests

By End-User

• Hospitals & Clinics
• Diagnostic Laboratories
• Research Laboratories & Institutes

By Region

• North America
  • The US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Korea
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East and Africa
  • GCC
  • Israel
  • South Africa
  • Rest of MEA

By Key Players:

• Thermo Fisher Scientific Inc.
• Roche Diagnostics
• PromoCell GmbH
• Abbott Laboratories
• Siemens Healthineers
• Danaher Corporation
• Sysmex Corporation
• Ortho Clinical Diagnostics
• Randox Laboratories
• FUJIFILM Wako Pure Chemical Corporation
• Abbexa Ltd.
• ACON Laboratories Inc.
• Arbor Assays Inc.
• ARKRAY Global Business Inc.
• Aviva Systems Biology
• among others.

Market Dynamics–

Kidney diseases are a leading cause of deaths around the world. The increase in the prevalence of chronic kidney diseases, coupled with booming geriatric populations, are major factors expected to boost the revenue growth prospects of the albumin & creatinine tests market, as such cases of kidney diseases require regular monitoring, i.e., in turn increasing the sales of products needed to analyze albumin & creatinine levels. Furthermore, the onset of the COVID-19 pandemic also increased the number of albumin tests being conducted as the virus has resulted in higher rates of hypoalbuminemia among patients.

However, the high costs of fully automated analyzers are a major factor that is anticipated to hamper this market to a certain extent. This occurs irrespective of small hospitals and clinics still preferring to use semi-automated or manual analyzers for the purposes of analysis.

Moreover, the integration of automated urine sediments, as well as the biochemical analysis of urine in one’s system, allows for the rapid analysis of samples. This factor in conjunction with various R&D activities aimed at the development of new products with higher accuracy test results are also expected to create additional lucrative opportunities for existing as well as emerging players in this market.

Competitive Landscape

Major players in this market are : Thermo Fisher Scientific Inc., Roche Diagnostics, PromoCell GmbH, Abbott Laboratories, Siemens Healthineers, Danaher Corporation, Sysmex Corporation, Ortho Clinical Diagnostics, Randox Laboratories, FUJIFILM Wako Pure Chemical Corporation, Abbexa Ltd., ACON Laboratories Inc., Arbor Assays Inc., ARKRAY Global Business Inc., and Aviva Systems Biology, among others.

Key Developments:

In 2020, NAT (Nitto Denko Asia Technical Centre) developed for Singaporean patients “ACT by Zensorium,” a more accessible early-detection device for kidney diseases.

For the Albumin & Creatinine Tests Market research study, the following years have been considered to estimate the market size: